BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
search help

Documents 1-25 out of 60 found
  Current Search:  naprelan: 163, naproxen: 1415  

100%
HTML
Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING
Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
Matching: naprelan naproxen Find similar documents More document info
100%
HTML
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING
Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
Matching: naprelan naproxen Find similar documents More document info
100%
HTML
Paragraph IV Patent Certifications
- DRUG NAME DOSAGE FORM STRENGTH RLD Acetaminophen Extended-release Tablets 650 mg Tylenol Acetaminophen/ Aspirin/ Caffeine Tablets 250 mg/250 mg/ 65 mg Excedrin (migraine) Acetaminophen and Tramadol Hydrochloride Tablets 325 mg/ 37.5 mg Ultracet Acyclovir Sodium1 Injection 50 mg/mL, 10 mL and 20 mL vials Zovirax Albuterol Sulfate Oral Syrup 2 mg(base)/ 5 mL Ventolin Albuterol...
Matching: naprelan naproxen Find similar documents More document info
100%
TEXT
http://www.fda.gov/cder/orange/appendix_a.txt
1/35 28, ETHINYL ESTRADIOL NABUMETONE, NABUMETONE NADOLOL, NADOLOL NAFAZAIR, NAPHAZOLINE HYDROCHLORIDE NAFCILLIN SODIUM, NAFCILLIN SODIUM NAFTIN, NAFTIFINE HYDROCHLORIDE NALBUPHINE HCL, NALBUPHINE HYDROCHLORIDE NALBUPHINE, NALBUPHINE HYDROCHLORIDE NALFON 200, FENOPROFEN CALCIUM NALFON, FENOPROFEN CALCIUM NALIDIXIC ACID, NALIDIXIC ACID APPENDIX A PRODUCT NAME INDEX NALLPEN IN PLASTIC...

Matching: naprelan naproxen Find similar documents More document info
100%
HTML
1998 Warning Letters and Untitled Letters to Pharmaceutical Companies
DDMAC 6/25 6/29 Maxipime (Cefepime HCl) for Injection Bristol-Myers Squibb DDMAC 6/29 8/3 Mircette (Desogestrel/Ethinyl Estradiol and Ethinyl Estradiol) Tablets Organon DDMAC 6/1 6/9 Naprelan (Naproxen Sodium) Tablets Wyeth-Ayerst DDMAC 6/8 6/29 Nasacort (Triamcinolone Acetonide) Rhone-Poulenc Rorer DDMAC 6/25 6/29 Nasonex (mometasone furoate monohydrate) nasal spray...
Matching: naprelan naproxen Find similar documents More document info
100%
HTML
Prescription and Over-the-Counter Drug Product List: 6/2003
>D> AP + WYETH AYERST 5,000 UNITS/VIAL N17055 001 JUN DISC >A> @ 5,000 UNITS/VIAL N17055 001 JUN DISC >D> AP + 10,000 UNITS/VIAL N17055 002 JUN DISC >A> @ 10,000 UNITS/VIAL N17055 002 JUN DISC GUANABENZ ACETATE TABLET; ORAL GUANABENZ ACETATE >D> AB WATSON LABS EQ 8MG BASE N74025 002 FEB 28, 1994 JUN CRLD >A> AB + EQ 8MG BASE N74025 002 FEB 28, 1994 JUN CRLD >D> WYTENSIN >D> AB WYETH...
author: AUTHOR
Matching: naprelan naproxen Find similar documents More document info
100%
HTML
Prescription and Over-the-Counter Drug Product List: 4/2003
45 -D- XCEL PHARMS 1MG/ML N05929 001 APR CFTG -A- AP + 1MG/ML N05929 001 APR CFTG -A- DIHYDROEROGTAMINE MESYLATE -A- AP PADDOCK 1MG/ML N40475 001 APR 28, 2003 APR NEWA DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE; ORAL -A- TAZTIA XT -A- AB4 ANDRX PHARMS 120MG N75401 001 APR 10, 2003 APR NEWA -A- AB4 180MG N75401 002 APR 10, 2003 APR NEWA -A- AB4 240MG N75401 003 APR 10, 2003 APR...
author: AUTHOR
Matching: naprelan naproxen Find similar documents More document info
100%
HTML
Prescription and Over-the-Counter Drug Product List: 3/2003
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE CAPSULE; ORAL FIORICET W/ CODEINE -D- AB + NOVARTIS 325MG;50MG;40MG;30MG N20232 001 JUL 30, 1992 MAR CAHN -A- AB + WATSON PHARMS 325MG;50MG;40MG;30MG N20232 001 JUL 30, 1992 MAR CAHN ACETAMINOPHEN; CODEINE PHOSPHATE TABLET; ORAL CODRIX -A- + ANDRX PHARMS 500MG;30MG N40441 001...
author: AUTHOR
Matching: naprelan naproxen Find similar documents More document info
100%
HTML
First-Time Generics - April 2003
Food and Drug Administration • Center for Drug Evaluation and Research Drug Information Search First-Time Generics - April 2003 - Generic Drug Name Generic Manufacturer Brand Name Approval Date 1 DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES, USP 120 MG, 180 MG, 240 MG, 300 MG, AND 360 MG (ONCE-A-DAY DOSAGE) ANDRX PHARMACEUTICALS, L.L.P
TIAZAC EXTENDED-RELEASE CAPSULES 4...
author: OGD
Matching: naprelan naproxen Find similar documents More document info
100%
HTML
FDA Drug Approvals List February 2002
Active Ingredient(s): BUSPIRONE HYDROCHLORIDE OTC/RX Status: RX Original Abbreviated Antibiotic Application#065022 Approval Date: 27-FEB-02 Trade Name: BACITRACIN ZINC AND POLYMYXIN B SULFATE Dosage Form: OINTMENT Applicant: ALTANA INC Active Ingredient(s): BACITRACIN ZINC; POLYMYXIN B SULFATE OTC/RX Status: RX Original Abbreviated Application# 075874 Approval Date: 26-FEB-02 Trade...
Matching: naprelan naproxen Find similar documents More document info
100%
HTML
Prescription and OTC Drug Product List 6/2002
-D- + WYETH AYERST 20,000 UNITS/VIAL N17055 003 JUN DISC -A- @ 20,000 UNITS/VIAL N17055 003 JUN DISC CHORIONIC GONADOTROPIN -D- + STERIS 2,000 UNITS/VIAL N17016 011 FEB 16, 1990 JUN DISC -A- @ 2,000 UNITS/VIAL N17016 011 FEB 16, 1990 JUN DISC GRANISETRON HYDROCHLORID E SOLUTION; ORAL KYTRIL -D- + ROCHE EQ 2MG BASE/10ML N21238 001 JUN 27, 2001 JUN DISC -A- @ EQ 2MG BASE/10ML N21238...
Matching: naprelan naproxen Find similar documents More document info
100%
HTML
NetSci: The Biotech YellowPages - Wyeth-Ayerst Research
Pharmaceutical and Biotechnology Companies - Wyeth-Ayerst Research Laboratories - Address: - 145 King of Prussia Radnor, PA 19087 Telephone: - 610-971-5400 Fax: - - Address: - 567 Ridge Road Monmouth Junction, NJ 08852-0200 Telephone: - 908-329-2300 Fax: - - Address: - North Middletown Road Pearle River, NY 10965 Telephone: - 914-732-5000 Fax: - - Web Site: - http://www.ahp.com...
Matching: naprelan naproxen Find similar documents More document info
100%
PDF
EVALUATION OF THE NEW YORK STATE ONECARD RX WORKERS COMPENSATION BENEFIT page 75


author: Julia Graffam
duplicates:
http://www.quintiles.com/NR/rdonlyres/esnb6djlmpmd267ms6votav3bmvxowbn6p7p3tdm3hpo33qoowyjxa2dtx6ssx4tapmrkojnqv3rxjukkkphpf33g6c/1503.pdf
Matching: Find similar documents More document info

100%
HTML
Naproxen Reverse phase Separation
Column: Whelk-O 1, 4.6mm x 25cm Catalog number: 786201 (R,R), or 786101 (S,S) Brand names: NAPROSYN, NAPRELAN, ANAPROX, ALEVE DRUG CLASS AND MECHANISM: Naproxen is a nonsteroidal anti-inflammatory drug (NSAID) effective in treating fever, pain, and inflammation in the body
As a group, NSAIDs are non-narcotic relievers of mild to moderate pain of many causes, including...
author: Louis Glunz
Matching: naprelan naproxen Find similar documents More document info
100%
HTML
Naproxen Enantiomer Separatio
Naproxen Enantiomer Separation Column: ULMO (R,R), 4.6mm x 25 cm Regis Catalog Number: 787200 (R,R), or 787100 (S,S) Link to molecular model of Naproxen Brand names: NAPROSYN, NAPRELAN, ANAPROX, ALEVE DRUG CLASS AND MECHANISM: Naproxen is a nonsteroidal anti-inflammatory drug (NSAID) effective in treating fever, pain, and inflammation in the body
As a group...
author: Louis Glunz
Matching: naprelan naproxen Find similar documents More document info
100%
HTML
naproxen normal phase separation
Column: Whelk-O 1, 4.6mm x 25cm Regis Catalog number: 786101 or 786201 Link to molecular model of Naproxen Brand names: NAPROSYN, NAPRELAN, ANAPROX, ALEVE DRUG CLASS AND MECHANISM: Naproxen is a nonsteroidal anti-inflammatory drug (NSAID) effective in treating fever, pain, and inflammation in the body
As a group, NSAIDs are non-narcotic relievers of mild to...
author: Carla Gresham
Matching: naprelan naproxen Find similar documents More document info
100%
PDF
Form 20-F (MASTER) v.3 96.F/A page 7
4 Current Products The primary Elan- developed products currently being marketed are as follows: Diltiazem: Elan has developed both a once- daily and a twice- daily, controlled- release formulation of diltiazem, a calcium channel blocker, utilizing Elan's SODAS technology. The once- daily formulation ...

author: diarmuid
Matching: naprelan naproxen Find similar documents More document info

100%
PDF
http://www.athenaneuro.com/Images/2_1755.pdf page 33
being amortized over the period expected to benefit from these products. Elan will continue to manufacture Naprelan and Verelan. Naprelan, a once- daily formulation of naproxen, is indicated for use in connection with mild to moderate pain, rheumatoid arthritis and a number of related inflammatory ...

Matching: naprelan naproxen Find similar documents More document info

100%
PDF
http://www.athenaneuro.com/Images/2_1755.pdf page 8
directly in the US. Verelan, a once- daily formulation of verapamil, is used to manage hypertension. Elan has also developed an enhanced formulation of Verelan called Verelan PM, which provides certain improved therapeutic benefits. On September 30, 1998, Elan entered into an agreement for the ...

Matching: naprelan naproxen Find similar documents More document info

100%
PDF
http://www.athenaneuro.com/Images/2_1755.pdf page 7
transdermal drug delivery systems. In connection with the acquisition, each outstanding share of Sano common stock was exchanged for 1.20 Elan ADSs, resulting in the issuance of approximately 12.7 million Elan ADSs valued at $377.0 million. Options granted by Sano prior to the acquisition date ...

Matching: naprelan naproxen Find similar documents More document info

100%
PDF
http://www.athenaneuro.com/Images/2_1755.pdf page 3
General Unless otherwise indicated, all amounts in this Annual Report on Form 20- F are expressed in United States dollars (''$ ''). All share and related information (such as per share information, options and warrants) has been adjusted to give effect, retroactively, to a two- for- one stock split ...

Matching: naprelan naproxen Find similar documents More document info

100%
PDF
Elan Annual Report page 38
ELAN CORP ORAT I O N , PLC A N N UAL REPORT 1998 P A G E 3 8 Product acquisitions On 9 October 1998 Elan licenced exclusive North American sales and distribution rights for Miguard, Vanguard Medica Group plc's novel anti- migraine therapy then in phase III of development. Vanguard filed a new drug application ...

author: Niall Connolly
Matching: naprelan naproxen Find similar documents More document info

100%
HTML
Prescription Drug Product List 1/96
PRESCRIPTION DRUG PRODUCT LIST 16TH EDITION RX DRUG PRODUCT LIST / CUMULATIVE SUPPLEMENT NUMBER 1 / JAN'96 ACETAMINOPHEN; CODEINE PHOSPHATE CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE TABLET; ORAL - ADD - ACETAMINOPHEN AND CODEINE PHOSPHATE SOLUTION; INTRAPERITONEAL - ADD - AA MIKART 300MG;60MG N89244 001 - ADD - DELFLEX W/ DEXTROSE 4.25% IN...
Matching: naprelan naproxen Find similar documents More document info
100%
PDF
http://www.fda.gov/cder/foi/appletter/2000/75416ta.pdf
ANDA 75- 416 March 17, 2000 Andrx Pharmaceuticals, Inc
47th Avenue Fort Lauderdale, FL 33314 Dear Madam: This is in reference to your abbreviated new drug application dated July 16, 1998, submitted pursuant to Section 505( j) of the Federal Food, Drug, and Cosmetic Act (Act), for Naproxen Sodium Extended- release Tablets, 500 mg (base)
Therefore, the application is...

Matching: naprelan naproxen Find similar documents More document info

100%
PDF
http://www.fda.gov/cder/foi/appletter/2000/75416ta.pdf page 1


Matching: naprelan naproxen Find similar documents More document info


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.